NeoLumina Bioscience Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 7, 2025 - 11:00 GMT

NeoLumina Partners with Catalent to Pioneer Psilocin Delivery, Marking a Major Leap in Psychedelic Med for Mental Health

Pioneering Precision: NeoLumina and Catalent Partner to Redefine Psilocin Delivery for Mental Health Treatment. VANCOUVER, BRITISH COLUMBIA, CANADA, November 7, 2025 /⁨EINPresswire.com⁩/ -- NeoLumina BioScience Inc., a pioneering clinical-stage …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 28, 2023 - 15:00 GMT

NeoLumina Bioscience In-Licenses Clinical-stage Psilocybin Product Candidate from Filament Health for Eating Disorders

PEX010 expands NeoLumina’s psychedelic product pipeline. Funding activity in process to advance clinical development. VANCOUVER, BRITISH COLUMBIA, CANADA, September 28, 2023 /⁨EINPresswire.com⁩/ -- NeoLumina Bioscience Inc. (“NeoLumina” or “the Company”) …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 30, 2023 - 14:00 GMT

NeoLumina Bioscience Advancing Development of Proprietary Psychedelic-based Therapeutic Medicines

Funding activity initiated to advance to human clinical development BURNABY, BC, CANADA, August 30, 2023 /⁨EINPresswire.com⁩/ -- NeoLumina Bioscience Inc. (“NeoLumina” or “the Company”) announces its launch as a biopharmaceutical company focused on the …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...